Healthcare Transactions and Regulatory

The Federal Trade Commission (“FTC”) announced a major crackdown on deceptive advertising for cannabidiol (“CBD”) products recently, taking aim at six sellers for mak...

Partner Roger Kuan, Associate Joan Wang, and Summer Associate Lyric Stephenson co-authored an article in IP & Technology Law Journal about the pressure faced by the U.S. government to promote...

Partners Michelle Jacobs and Suzie Trigg and Associates Jennifer Kreick and Kayla Cristales authored an article in Bloomberg Law examining the scope of PREP Act immunity for COVID-19 liabilit...

As healthcare providers respond to increased demands on supplies and resources due to the COVID-19 pandemic, regulators have issued certain flexibilities and guidance in responding to the public healt...

Today, the federal government enacted the Paycheck Protection Program and Health Care Enhancement Act (the “PPP/HCE Act”) to provide additional funding for loan and grant pro...

In response to the economic impact of the COVID-19 pandemic, the federal government has passed several new laws to provide trillions of dollars of funding to affected businesses and individuals.

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), a historic $2 trillion relief package signed into law on March 27, 2020, seeks to address the econom...

We recently discussed how the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) allocates $100 billion to the Public Health and Social Service Emergency Fu...

Federal and state agencies continue to deliver tools and information to help healthcare providers respond to the COVID-19 pandemic since the President declared the COVID-19 outbreak

The FDA has announced procedures